|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2005-10-19
|
|
pubmed:abstractText |
The effect of octreotide plus interferon-alpha versus octreotide monotherapy on the primary study end points of time to treatment failure (progression, death, stop of study treatment) and long-term survival was investigated in patients with progressive metastatic neuroendocrine foregut (mainly pancreatic) and midgut tumors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1542-3565
|
|
pubmed:author |
pubmed-author:ArnoldChristian NCN,
pubmed-author:ArnoldRudolfR,
pubmed-author:BarthPeterP,
pubmed-author:HiddemannWolfgangW,
pubmed-author:KloseKlaus-JochenKJ,
pubmed-author:KollerMichaelM,
pubmed-author:MüllerHans-HelgeHH,
pubmed-author:MollRolandR,
pubmed-author:PavelMarianneM,
pubmed-author:RinkeAnjaA,
pubmed-author:Schade-BrittingerCarmenC,
pubmed-author:Schmidt-LauberMartinM,
pubmed-author:SchmidtChristinaC,
pubmed-author:UnterhaltMichaelM,
pubmed-author:WiedMatthiasM,
pubmed-author:ZamzowKarinK
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
3
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
761-71
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16234004-Adolescent,
pubmed-meshheading:16234004-Adult,
pubmed-meshheading:16234004-Aged,
pubmed-meshheading:16234004-Antineoplastic Agents,
pubmed-meshheading:16234004-Chromogranin A,
pubmed-meshheading:16234004-Chromogranins,
pubmed-meshheading:16234004-Female,
pubmed-meshheading:16234004-Germany,
pubmed-meshheading:16234004-Humans,
pubmed-meshheading:16234004-Hydroxyindoleacetic Acid,
pubmed-meshheading:16234004-Injections, Subcutaneous,
pubmed-meshheading:16234004-Interferon-alpha,
pubmed-meshheading:16234004-Intestinal Neoplasms,
pubmed-meshheading:16234004-Ki-67 Antigen,
pubmed-meshheading:16234004-Male,
pubmed-meshheading:16234004-Middle Aged,
pubmed-meshheading:16234004-Octreotide,
pubmed-meshheading:16234004-Pancreatic Neoplasms,
pubmed-meshheading:16234004-Quality of Life
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors: a randomized trial.
|
|
pubmed:affiliation |
Division of Gastroenterology and Endocrinology, Department of Internal Medicine, Philipps University, Marburg, Germany. arnoldr@mailer.uni-marburg.de
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
